Affectis Pharmaceuticals' Series A Round

Affectis Pharmaceuticals raised a round of funding on November 10, 2003.

Affectis Pharmaceuticals, fka neuronova, is a biopharmaceutical company developing drugs for the treatment of psychiatric and inflammatory disorders.…

Articles about Affectis Pharmaceuticals' Series A Round: